Pregnant Diabetic Women's Babies at Risk
Posted on: Tuesday, 5 September 2006, 18:00 CDT
British researchers are identifying new methods for early and accurate monitoring of the risks faced by pregnant diabetic women.
Women with type 1 or type 2 diabetes have four times as many stillbirths as non-diabetic women.
Warwick University Medical School researchers have focused on the alterations in the hormonal metabolism of pregnant women and the metabolic signals between mother and fetus.
Dr. Harpal Randeva, Dr. Paul O'Hare, Dr. Dimitris Grammatopoulos and Manu Vatish found adiponectin levels -- a signaling molecule, mainly produced by fat cells -- were higher in pregnant women with type 1 diabetes at all stages of the study compared with the non-diabetic patients.
The researchers believe that the fetus produces adiponectin to protect itself from an adverse environment.
The findings, published in Clinical Endocrinology, may be of vital importance since altered adiponectin levels could now be used to help give effective and early monitoring of the risks faced by women with type 1 diabetes and identify babies who are at risk.
Source: United Press International
Related Articles
- Multivu Video Feed: JDRF International Chairman Mary Tyler Moore Testifies on the Need for Federal Funding for Type 1 Diabetes Research
- Supermodel Izabel Goulart Partners With Diabetes Research Institute Foundation as International Ambassador
- University of Minnesota Receives $40 Million for Type 1 Diabetes Research
- Bayhill Therapeutics and the Juvenile Diabetes Research Foundation Announce Research Collaboration for the Clinical Development of a Novel Immunotherapeutic DNA Vaccine for Type 1 Diabetes
- SmartCells and JDRF Partner in Diabetes Research
- SmartCells, Inc. And Juvenile Diabetes Research Foundation Announce Partnership and $1 Million Funding to Advance SmartInsulin(TM) for Type 1 Diabetes
- New Diabetes Research To Be Presented at FOCIS Annual Meeting
- Juvenile Diabetes Research Foundation Names The City of Hope a JDRF Islet Cell Transplant Center
- Determinants of Diabetes-Attributable Non-Blood Glucose-Lowering Medication Costs in Type 2 Diabetes: The Fremantle Diabetes Study
 |
 |
User Comments (0)
RSS Feeds